Global Lou Gehrigs Disease Market Research Report 2019

Table of Contents

Executive Summary

1 Lou Gehrigs Disease Market Overview

• 1.1 Product Overview and Scope of Lou Gehrigs Disease
• 1.2 Lou Gehrigs Disease Segment by Type
  • 1.2.1 Global Lou Gehrigs Disease Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Riluzole
  • 1.2.3 Edaravone (Radicava)
• 1.3 Lou Gehrigs Disease Segment by Application
  • 1.3.1 Lou Gehrigs Disease Consumption Comparison by Application (2014-2025)
  • 1.3.2 Hospital Pharmacies
  • 1.3.3 Retail & Online Pharmacie
• 1.4 Global Lou Gehrigs Disease Market by Region
  • 1.4.1 Global Lou Gehrigs Disease Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Lou Gehrigs Disease Market Size
  • 1.5.1 Global Lou Gehrigs Disease Revenue (2014-2025)
  • 1.5.2 Global Lou Gehrigs Disease Production (2014-2025)

2 Global Lou Gehrigs Disease Market Competition by Manufacturers

• 2.1 Global Lou Gehrigs Disease Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Lou Gehrigs Disease Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Lou Gehrigs Disease Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Lou Gehrigs Disease Production Sites, Area Served, Product Types
• 2.5 Lou Gehrigs Disease Market Competitive Situation and Trends
  • 2.5.1 Lou Gehrigs Disease Market Concentration Rate
  • 2.5.2 Lou Gehrigs Disease Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Lou Gehrigs Disease Production Market Share by Regions

• 3.1 Global Lou Gehrigs Disease Production Market Share by Regions
• 3.2 Global Lou Gehrigs Disease Revenue Market Share by Regions (2014-2019)
• 3.3 Global Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Lou Gehrigs Disease Production
  • 3.4.1 North America Lou Gehrigs Disease Production Growth Rate (2014-2019)
  • 3.4.2 North America Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Lou Gehrigs Disease Production
  • 3.5.1 Europe Lou Gehrigs Disease Production Growth Rate (2014-2019)
  • 3.5.2 Europe Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Lou Gehrigs Disease Production (2014-2019)
  • 3.6.1 China Lou Gehrigs Disease Production Growth Rate (2014-2019)
  • 3.6.2 China Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Lou Gehrigs Disease Production (2014-2019)
  • 3.7.1 Japan Lou Gehrigs Disease Production Growth Rate (2014-2019)
  • 3.7.2 Japan Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Lou Gehrigs Disease Consumption by Regions

• 4.1 Global Lou Gehrigs Disease Consumption by Regions
• 4.2 North America Lou Gehrigs Disease Consumption (2014-2019)
• 4.3 Europe Lou Gehrigs Disease Consumption (2014-2019)
• 4.4 China Lou Gehrigs Disease Consumption (2014-2019)
• 4.5 Japan Lou Gehrigs Disease Consumption (2014-2019)

5 Global Lou Gehrigs Disease Production, Revenue, Price Trend by Type

• 5.1 Global Lou Gehrigs Disease Production Market Share by Type (2014-2019)
• 5.2 Global Lou Gehrigs Disease Revenue Market Share by Type (2014-2019)
• 5.3 Global Lou Gehrigs Disease Price by Type (2014-2019)
• 5.4 Global Lou Gehrigs Disease Production Growth by Type (2014-2019)

6 Global Lou Gehrigs Disease Market Analysis by Applications

• 6.1 Global Lou Gehrigs Disease Consumption Market Share by Application (2014-2019)
• 6.2 Global Lou Gehrigs Disease Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Lou Gehrigs Disease Business

• 7.1 AB Science
  • 7.1.1 AB Science Lou Gehrigs Disease Production Sites and Area Served
  • 7.1.2 Lou Gehrigs Disease Product Introduction, Application and Specification
  • 7.1.3 AB Science Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 Avicena Group
  • 7.2.1 Avicena Group Lou Gehrigs Disease Production Sites and Area Served
  • 7.2.2 Lou Gehrigs Disease Product Introduction, Application and Specification
  • 7.2.3 Avicena Group Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Biogen
  • 7.3.1 Biogen Lou Gehrigs Disease Production Sites and Area Served
  • 7.3.2 Lou Gehrigs Disease Product Introduction, Application and Specification
  • 7.3.3 Biogen Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 BrainStorm Therapeutics
  • 7.4.1 BrainStorm Therapeutics Lou Gehrigs Disease Production Sites and Area Served
  • 7.4.2 Lou Gehrigs Disease Product Introduction, Application and Specification
  • 7.4.3 BrainStorm Therapeutics Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Covis Pharmaceutical Inc.
  • 7.5.1 Covis Pharmaceutical Inc. Lou Gehrigs Disease Production Sites and Area Served
  • 7.5.2 Lou Gehrigs Disease Product Introduction, Application and Specification
  • 7.5.3 Covis Pharmaceutical Inc. Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 Cytokinetics Inc.
  • 7.6.1 Cytokinetics Inc. Lou Gehrigs Disease Production Sites and Area Served
  • 7.6.2 Lou Gehrigs Disease Product Introduction, Application and Specification
  • 7.6.3 Cytokinetics Inc. Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Eisai Co. Ltd.
  • 7.7.1 Eisai Co. Ltd. Lou Gehrigs Disease Production Sites and Area Served
  • 7.7.2 Lou Gehrigs Disease Product Introduction, Application and Specification
  • 7.7.3 Eisai Co. Ltd. Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 GlaxoSmithKline plc.
  • 7.8.1 GlaxoSmithKline plc. Lou Gehrigs Disease Production Sites and Area Served
  • 7.8.2 Lou Gehrigs Disease Product Introduction, Application and Specification
  • 7.8.3 GlaxoSmithKline plc. Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Ionis Pharmaceuticals, Inc.
  • 7.9.1 Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Production Sites and Area Served
  • 7.9.2 Lou Gehrigs Disease Product Introduction, Application and Specification
  • 7.9.3 Ionis Pharmaceuticals, Inc. Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Mitsubishi Tanabe Pharma Corp.
  • 7.10.1 Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Production Sites and Area Served
  • 7.10.2 Lou Gehrigs Disease Product Introduction, Application and Specification
  • 7.10.3 Mitsubishi Tanabe Pharma Corp. Lou Gehrigs Disease Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Neuralstem Inc.
• 7.12 Neuraltus Pharmaceuticals Inc.
• 7.13 Newron Pharmaceuticals S.p.A.
• 7.14 Nutra Pharma Corp.
• 7.15 Pharnext SAS
• 7.16 Q-Therapeutics Inc.

8 Lou Gehrigs Disease Manufacturing Cost Analysis

• 8.1 Lou Gehrigs Disease Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Lou Gehrigs Disease
• 8.4 Lou Gehrigs Disease Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Lou Gehrigs Disease Distributors List
• 9.3 Lou Gehrigs Disease Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Lou Gehrigs Disease Market Forecast

• 11.1 Global Lou Gehrigs Disease Production, Revenue Forecast
  • 11.1.1 Global Lou Gehrigs Disease Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Lou Gehrigs Disease Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Lou Gehrigs Disease Price and Trend Forecast (2019-2025)
• 11.2 Global Lou Gehrigs Disease Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Lou Gehrigs Disease Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Lou Gehrigs Disease Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Lou Gehrigs Disease Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Lou Gehrigs Disease Production, Revenue Forecast (2019-2025)
• 11.3 Global Lou Gehrigs Disease Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Lou Gehrigs Disease Consumption Forecast (2019-2025)
  • 11.3.2 Europe Lou Gehrigs Disease Consumption Forecast (2019-2025)
  • 11.3.3 China Lou Gehrigs Disease Consumption Forecast (2019-2025)
  • 11.3.4 Japan Lou Gehrigs Disease Consumption Forecast (2019-2025)
• 11.4 Global Lou Gehrigs Disease Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Lou Gehrigs Disease Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List